8i Acquisition 2 Corp. amends SPAC deal with EUDA Health; consideration cut to $140M

EUDA Health Holdings Ltd

Initial consideration reduced to $140M, payable in LAX ordinary shares at $10.00 per share.
Earnout: up to 4M additional shares based on share price thresholds ($15/$20) or revenue/net income targets (2023: $20.1M/$3.6M; 2024: $40.1M/$10.1M).
Indemnification basket reduced from $2.5M to $636,636; seller must cover specific liabilities including unpaid receivable of SGD 5.15M.
Pro forma enterprise value of combined company estimated at $172M; EUDA Health revised projections exclude regional expansion due to COVID delays.
Second Amendment also expands seller indemnity for employment law compliance and property insurance obligations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.